Does Merck’s Share Price Around 100 Offer Long Term Value in 2025?
How Merck’s Recent Performance Frames the Valuation Story
With Merck’s share price hovering just above the 100 dollar mark, many investors are wondering whether they are looking at a solid long term compounder or a stock that has already priced in most of its upside. The recent performance numbers offer a useful starting point for framing that valuation debate.
Over the last week, Merck has inched up around 0.8%, adding to a stronger 6.4% gain over the past month and a more modest 1.9% return year to date. Stretch that lens out further, and the stock’s 7.0% return over the last year and 55.0% gain over five years highlight a business that has rewarded patient shareholders, even if the 3 year return of around minus 1.0% shows that…
